Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

NGS based RNA sequencing Market

ID: MRFR/HC/20519-HCR
128 Pages
Satyendra Maurya
Last Updated: April 15, 2026

NGS-based RNA-sequencing Market Research Report: Size, Share, Trend Analysis By Product and Service (Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services and Data Analysis, Storage and Management), By Technology (Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing (SMRT), Nanopore Sequencing), By Applications (Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics), By End-User (Research and Academia, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

NGS based RNA sequencing Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Product and Service (USD Billion) | |
      1. 4.1.1 Sample Preparation Products | |
      2. 4.1.2 Sequencing Platforms and Consumables | |
      3. 4.1.3 Sequencing Services | |
      4. 4.1.4 Data Analysis, Storage and Management |
    2. 4.2 Healthcare, BY Technology (USD Billion) | |
      1. 4.2.1 Sequencing by Synthesis (SBS) | |
      2. 4.2.2 Ion Semiconductor Sequencing | |
      3. 4.2.3 Single-molecule Real-time Sequencing (SMRT) | |
      4. 4.2.4 Nanopore Sequencing |
    3. 4.3 Healthcare, BY Application (USD Billion) | |
      1. 4.3.1 Expression Profiling Analysis | |
      2. 4.3.2 Small RNA Sequencing | |
      3. 4.3.3 De Novo Transcriptome Assembly | |
      4. 4.3.4 Variant Calling | |
      5. 4.3.5 Transcriptome Epigenetics |
    4. 4.4 Healthcare, BY End-User (USD Billion) | |
      1. 4.4.1 Research and Academia | |
      2. 4.4.2 Hospitals and Clinics | |
      3. 4.4.3 Pharmaceutical and Biotechnology Companies |
    5. 4.5 Healthcare, BY Region (USD Billion) | |
      1. 4.5.1 North America | | |
        1. 4.5.1.1 US | | |
        2. 4.5.1.2 Canada | |
      2. 4.5.2 Europe | | |
        1. 4.5.2.1 Germany | | |
        2. 4.5.2.2 UK | | |
        3. 4.5.2.3 France | | |
        4. 4.5.2.4 Russia | | |
        5. 4.5.2.5 Italy | | |
        6. 4.5.2.6 Spain | | |
        7. 4.5.2.7 Rest of Europe | |
      3. 4.5.3 APAC | | |
        1. 4.5.3.1 China | | |
        2. 4.5.3.2 India | | |
        3. 4.5.3.3 Japan | | |
        4. 4.5.3.4 South Korea | | |
        5. 4.5.3.5 Malaysia | | |
        6. 4.5.3.6 Thailand | | |
        7. 4.5.3.7 Indonesia | | |
        8. 4.5.3.8 Rest of APAC | |
      4. 4.5.4 South America | | |
        1. 4.5.4.1 Brazil | | |
        2. 4.5.4.2 Mexico | | |
        3. 4.5.4.3 Argentina | | |
        4. 4.5.4.4 Rest of South America | |
      5. 4.5.5 MEA | | |
        1. 4.5.5.1 GCC Countries | | |
        2. 4.5.5.2 South Africa | | |
        3. 4.5.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Illumina (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Thermo Fisher Scientific (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Roche (CH) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Qiagen (DE) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 PerkinElmer (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 BGI (CN) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Agilent Technologies (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Oxford Nanopore Technologies (GB) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 Macrogen (KR) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY PRODUCT AND SERVICE |
    7. 6.4 US MARKET ANALYSIS BY TECHNOLOGY |
    8. 6.5 US MARKET ANALYSIS BY APPLICATION |
    9. 6.6 US MARKET ANALYSIS BY END-USER |
    10. 6.7 CANADA MARKET ANALYSIS BY PRODUCT AND SERVICE |
    11. 6.8 CANADA MARKET ANALYSIS BY TECHNOLOGY |
    12. 6.9 CANADA MARKET ANALYSIS BY APPLICATION |
    13. 6.10 CANADA MARKET ANALYSIS BY END-USER |
    14. 6.11 EUROPE MARKET ANALYSIS |
    15. 6.12 GERMANY MARKET ANALYSIS BY PRODUCT AND SERVICE |
    16. 6.13 GERMANY MARKET ANALYSIS BY TECHNOLOGY |
    17. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION |
    18. 6.15 GERMANY MARKET ANALYSIS BY END-USER |
    19. 6.16 UK MARKET ANALYSIS BY PRODUCT AND SERVICE |
    20. 6.17 UK MARKET ANALYSIS BY TECHNOLOGY |
    21. 6.18 UK MARKET ANALYSIS BY APPLICATION |
    22. 6.19 UK MARKET ANALYSIS BY END-USER |
    23. 6.20 FRANCE MARKET ANALYSIS BY PRODUCT AND SERVICE |
    24. 6.21 FRANCE MARKET ANALYSIS BY TECHNOLOGY |
    25. 6.22 FRANCE MARKET ANALYSIS BY APPLICATION |
    26. 6.23 FRANCE MARKET ANALYSIS BY END-USER |
    27. 6.24 RUSSIA MARKET ANALYSIS BY PRODUCT AND SERVICE |
    28. 6.25 RUSSIA MARKET ANALYSIS BY TECHNOLOGY |
    29. 6.26 RUSSIA MARKET ANALYSIS BY APPLICATION |
    30. 6.27 RUSSIA MARKET ANALYSIS BY END-USER |
    31. 6.28 ITALY MARKET ANALYSIS BY PRODUCT AND SERVICE |
    32. 6.29 ITALY MARKET ANALYSIS BY TECHNOLOGY |
    33. 6.30 ITALY MARKET ANALYSIS BY APPLICATION |
    34. 6.31 ITALY MARKET ANALYSIS BY END-USER |
    35. 6.32 SPAIN MARKET ANALYSIS BY PRODUCT AND SERVICE |
    36. 6.33 SPAIN MARKET ANALYSIS BY TECHNOLOGY |
    37. 6.34 SPAIN MARKET ANALYSIS BY APPLICATION |
    38. 6.35 SPAIN MARKET ANALYSIS BY END-USER |
    39. 6.36 REST OF EUROPE MARKET ANALYSIS BY PRODUCT AND SERVICE |
    40. 6.37 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY |
    41. 6.38 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
    42. 6.39 REST OF EUROPE MARKET ANALYSIS BY END-USER |
    43. 6.40 APAC MARKET ANALYSIS |
    44. 6.41 CHINA MARKET ANALYSIS BY PRODUCT AND SERVICE |
    45. 6.42 CHINA MARKET ANALYSIS BY TECHNOLOGY |
    46. 6.43 CHINA MARKET ANALYSIS BY APPLICATION |
    47. 6.44 CHINA MARKET ANALYSIS BY END-USER |
    48. 6.45 INDIA MARKET ANALYSIS BY PRODUCT AND SERVICE |
    49. 6.46 INDIA MARKET ANALYSIS BY TECHNOLOGY |
    50. 6.47 INDIA MARKET ANALYSIS BY APPLICATION |
    51. 6.48 INDIA MARKET ANALYSIS BY END-USER |
    52. 6.49 JAPAN MARKET ANALYSIS BY PRODUCT AND SERVICE |
    53. 6.50 JAPAN MARKET ANALYSIS BY TECHNOLOGY |
    54. 6.51 JAPAN MARKET ANALYSIS BY APPLICATION |
    55. 6.52 JAPAN MARKET ANALYSIS BY END-USER |
    56. 6.53 SOUTH KOREA MARKET ANALYSIS BY PRODUCT AND SERVICE |
    57. 6.54 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY |
    58. 6.55 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
    59. 6.56 SOUTH KOREA MARKET ANALYSIS BY END-USER |
    60. 6.57 MALAYSIA MARKET ANALYSIS BY PRODUCT AND SERVICE |
    61. 6.58 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY |
    62. 6.59 MALAYSIA MARKET ANALYSIS BY APPLICATION |
    63. 6.60 MALAYSIA MARKET ANALYSIS BY END-USER |
    64. 6.61 THAILAND MARKET ANALYSIS BY PRODUCT AND SERVICE |
    65. 6.62 THAILAND MARKET ANALYSIS BY TECHNOLOGY |
    66. 6.63 THAILAND MARKET ANALYSIS BY APPLICATION |
    67. 6.64 THAILAND MARKET ANALYSIS BY END-USER |
    68. 6.65 INDONESIA MARKET ANALYSIS BY PRODUCT AND SERVICE |
    69. 6.66 INDONESIA MARKET ANALYSIS BY TECHNOLOGY |
    70. 6.67 INDONESIA MARKET ANALYSIS BY APPLICATION |
    71. 6.68 INDONESIA MARKET ANALYSIS BY END-USER |
    72. 6.69 REST OF APAC MARKET ANALYSIS BY PRODUCT AND SERVICE |
    73. 6.70 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY |
    74. 6.71 REST OF APAC MARKET ANALYSIS BY APPLICATION |
    75. 6.72 REST OF APAC MARKET ANALYSIS BY END-USER |
    76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
    77. 6.74 BRAZIL MARKET ANALYSIS BY PRODUCT AND SERVICE |
    78. 6.75 BRAZIL MARKET ANALYSIS BY TECHNOLOGY |
    79. 6.76 BRAZIL MARKET ANALYSIS BY APPLICATION |
    80. 6.77 BRAZIL MARKET ANALYSIS BY END-USER |
    81. 6.78 MEXICO MARKET ANALYSIS BY PRODUCT AND SERVICE |
    82. 6.79 MEXICO MARKET ANALYSIS BY TECHNOLOGY |
    83. 6.80 MEXICO MARKET ANALYSIS BY APPLICATION |
    84. 6.81 MEXICO MARKET ANALYSIS BY END-USER |
    85. 6.82 ARGENTINA MARKET ANALYSIS BY PRODUCT AND SERVICE |
    86. 6.83 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY |
    87. 6.84 ARGENTINA MARKET ANALYSIS BY APPLICATION |
    88. 6.85 ARGENTINA MARKET ANALYSIS BY END-USER |
    89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT AND SERVICE |
    90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY |
    91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
    92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USER |
    93. 6.90 MEA MARKET ANALYSIS |
    94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT AND SERVICE |
    95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY |
    96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
    97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END-USER |
    98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT AND SERVICE |
    99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY |
    100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
    101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END-USER |
    102. 6.99 REST OF MEA MARKET ANALYSIS BY PRODUCT AND SERVICE |
    103. 6.100 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY |
    104. 6.101 REST OF MEA MARKET ANALYSIS BY APPLICATION |
    105. 6.102 REST OF MEA MARKET ANALYSIS BY END-USER |
    106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
    107. 6.104 RESEARCH PROCESS OF MRFR |
    108. 6.105 DRO ANALYSIS OF HEALTHCARE |
    109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
    112. 6.109 HEALTHCARE, BY PRODUCT AND SERVICE, 2024 (% SHARE) |
    113. 6.110 HEALTHCARE, BY PRODUCT AND SERVICE, 2024 TO 2035 (USD Billion) |
    114. 6.111 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE) |
    115. 6.112 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion) |
    116. 6.113 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
    117. 6.114 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion) |
    118. 6.115 HEALTHCARE, BY END-USER, 2024 (% SHARE) |
    119. 6.116 HEALTHCARE, BY END-USER, 2024 TO 2035 (USD Billion) |
    120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    121. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY END-USER, 2025-2035 (USD Billion) |
    123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY END-USER, 2025-2035 (USD Billion) |
    124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY END-USER, 2025-2035 (USD Billion) |
    125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY END-USER, 2025-2035 (USD Billion) |
    126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY END-USER, 2025-2035 (USD Billion) |
    127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY END-USER, 2025-2035 (USD Billion) |
    128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY END-USER, 2025-2035 (USD Billion) |
    129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY END-USER, 2025-2035 (USD Billion) |
    130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY END-USER, 2025-2035 (USD Billion) |
    131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY END-USER, 2025-2035 (USD Billion) |
    132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY END-USER, 2025-2035 (USD Billion) |
    133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY END-USER, 2025-2035 (USD Billion) |
    134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY END-USER, 2025-2035 (USD Billion) |
    135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY END-USER, 2025-2035 (USD Billion) |
    136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY END-USER, 2025-2035 (USD Billion) |
    137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY END-USER, 2025-2035 (USD Billion) |
    138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY END-USER, 2025-2035 (USD Billion) |
    139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY END-USER, 2025-2035 (USD Billion) |
    140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY END-USER, 2025-2035 (USD Billion) |
    141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY END-USER, 2025-2035 (USD Billion) |
    142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY END-USER, 2025-2035 (USD Billion) |
    143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY END-USER, 2025-2035 (USD Billion) |
    144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY END-USER, 2025-2035 (USD Billion) |
    145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY END-USER, 2025-2035 (USD Billion) |
    146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY END-USER, 2025-2035 (USD Billion) |
    147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY END-USER, 2025-2035 (USD Billion) |
    148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY END-USER, 2025-2035 (USD Billion) |
    149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY END-USER, 2025-2035 (USD Billion) |
    150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY PRODUCT AND SERVICE, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY END-USER, 2025-2035 (USD Billion) |
    151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    152. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Product and Service (USD Billion, 2025-2035)

  • Sample Preparation Products
  • Sequencing Platforms and Consumables
  • Sequencing Services
  • Data Analysis, Storage and Management

Healthcare By Technology (USD Billion, 2025-2035)

  • Sequencing by Synthesis (SBS)
  • Ion Semiconductor Sequencing
  • Single-molecule Real-time Sequencing (SMRT)
  • Nanopore Sequencing

Healthcare By Application (USD Billion, 2025-2035)

  • Expression Profiling Analysis
  • Small RNA Sequencing
  • De Novo Transcriptome Assembly
  • Variant Calling
  • Transcriptome Epigenetics

Healthcare By End-User (USD Billion, 2025-2035)

  • Research and Academia
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,590 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions